U.S. Surgitech wins patent for disposable SurgyNeedle

U.S. Surgitech said July 20, 2026, that the U.S. Patent and Trademark Office has issued a patent for SurgyNeedle™, a single-use device designed to replace reusable aspiration and irrigation needles in minimally invasive procedures. The company says the design is meant to reduce cross-contamination and help address surgical site infections, which carry a multibillion-dollar annual cost in U.S. healthcare.

Why it matters: - Reusable laparoscopic needles must be reprocessed, which can create safety and workflow risks when cleaning is incomplete or inconsistent. - Surgical site infections remain a major public health problem, with an estimated $3.3 billion annual economic burden in the U.S. healthcare system. - SurgyNeedle™ is designed as a disposable replacement that aims to reduce cross-contamination and improve operating-room safety.

What happened: - U.S. Surgitech announced that the U.S. Patent and Trademark Office issued a patent for SurgyNeedle™ under Application No. 16/359,423. - The announcement was made July 20, 2026, from Carol Stream, Illinois. - The patent marks a milestone in U.S. Surgitech’s push to make minimally invasive surgery safer through single-use device design.

The details: - SurgyNeedle™ – Aspiration Needle features a flexible, transparent shaft and an ultra-sharp tip. - The aspiration needle is built to give surgeons real-time visibility into fluid while providing maneuverability and controlled tissue penetration. - U.S. Surgitech says the aspiration needle is intended for laparoscopic, robotic, and endoscopic procedures. - SurgyNeedle™ – Single Site Injection Needle uses the same transparent-shaft approach for endoscopic urology. - The injection needle is designed for controlled deployment and millimeter-level precision when administering muscle-blocking agents or other fluids. - The company says the injection needle is especially suited for intradetrusor injections, where accuracy is critical. - The two instruments reflect U.S. Surgitech’s focus on practical, single-use technologies for operating-room use. - More information about SurgyNeedle™ is available at surgyneedle.com.

Between the lines: - The patent adds formal protection around a product category aimed at replacing a long-standing reusable instrument in minimally invasive surgery. - The device pitch centers on infection prevention and procedural control, two pain points that can influence both clinical outcomes and hospital costs. - U.S. Surgitech is positioning the product line around specific specialty uses rather than a broad general-purpose tool.

What's next: - U.S. Surgitech is likely to use the patent to support commercial rollout, adoption discussions, and further product development. - The company’s broader focus remains medical and surgical devices designed to improve surgical performance and patient safety. - U.S. Surgitech says it will continue developing practical solutions for real-world clinical challenges and procedural outcomes.